NASEM: Building Parents’ Confidence in COVID-19 Vaccines
NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.
NASEM offers recommendations for communicating with parents of young children about COVID-19 vaccines.
A single-session, nurse-led clinic staff education program on medication adherence leads to increased knowledge and practice changes at a FQHC.
Although ADHD symptoms may fluctuate over a patient’s life, symptoms often persist into adulthood.
Experts discuss emerging safety data on administration of COVID-19 mRNA vaccines during pregnancy.
The MAT Act would allow all clinicians with standard controlled medication licenses to prescribe buprenorphine for opioid use disorder.
Updated guidance suggests possibly pausing methotrexate use for 2 weeks after COVID-19 vaccination in patients with psoriasis or psoriatic arthritis.